← Leaderboards
Olivier Thibault
University Of Kentucky
$6,789,321
Attributed
$8,914,492
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,914,492 · 5
By mechanism
R01$6,203,864 · 2
P01$2,402,429 · 2
R21$308,199 · 1
Top collaborators
- Brian M Bennett5 shared
- Bruce A. Berkowitz5 shared
- Geoffrey G Murphy5 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- James W Geddes$9,073,491
- Nada Micovic Porter$3,721,783
- Ramon C. Sun$5,151,131
- Bernard Mark Evers$41,615,341
- Christopher Mark Norris$15,768,108
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseLearningNeuronsAgingImageHippocampus (Brain)TissuesS Disease ModelMemoryMediatingIn VivoCognitive FunctionAgedPathway InteractionsBrainInsulinGlucoseSliceElectrophysiology (Science)Functional DisorderBehaviorMetabolicRodent
Grant awards (22)
Project 2 - Astrocytic insulin signaling and AD$565,519
P01 · FY2025 · AG · contact PI
Project 2 - Astrocytic insulin signaling and AD$613,046
P01 · FY2024 · AG · contact PI
Project 2 - Astrocytic insulin signaling and AD$602,515
P01 · FY2023 · AG · contact PI
Project 2 - Astrocytic insulin signaling and AD$621,349
P01 · FY2022 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2021 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2020 · AG
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2019 · AG
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$332,818
R01 · FY2019 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,144
R01 · FY2018 · AG
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$322,349
R01 · FY2018 · AG · contact PI
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$218,206
R01 · FY2018 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$599,186
R01 · FY2017 · AG
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$348,770
R01 · FY2017 · AG · contact PI
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$369,914
R01 · FY2016 · AG · contact PI
A healthy brain aging strategy to restore insulin signaling and Ca homeostasis$347,897
R01 · FY2015 · AG · contact PI
Metabolic syndrome and hippocampal Ca2+ dysregulation in aging memory decline$268,391
R01 · FY2013 · AG · contact PI
Metabolic syndrome and hippocampal Ca2+ dysregulation in aging memory decline$284,011
R01 · FY2012 · AG · contact PI
Metabolic syndrome and hippocampal Ca2+ dysregulation in aging memory decline$284,011
R01 · FY2011 · AG · contact PI
Metabolic syndrome and hippocampal Ca2+ dysregulation in aging-related memory dec$295,475
R01 · FY2010 · AG · contact PI
Metabolic syndrome and hippocampal Ca2+ dysregulation in aging-related memory dec$298,460
R01 · FY2009 · AG · contact PI
Mechanisms and use of antidiabetic agents in brain aging and Alzheimer's disease$152,543
R21 · FY2008 · AG · contact PI
Mechanisms and use of antidiabetic agents in brain aging and Alzheimer's disease$155,656
R21 · FY2007 · AG · contact PI